MR
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
27.673
Exchange
XNAS - Nasdaq
8.5 B
Last period Cash and equivalents ,USD
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also Moderna
Company Analysis
MRNA valuation, rating, competitors, insights and company profile
Eyestock Rating
MRNA financial analysis by Eyestock methodology
Valuation
MRNA valuation using historical relative method
Statements
MRNA Income Statements, Balance Sheet and Cash Flow Statements
Dividends
MRNA dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
Moderna`s Cash and equivalents for the period ended 2024-06-30 are 8.5 B USD
